Phase I, Healthy Subject, Safety, Tolerability and Pharmacokinetic Study of an M1 Agonist to Treat Cognitive Impairment
Clinical trial NCT02291783 · COMPLETED
Trial details
- NCT number
- NCT02291783
- Sponsor
- Nxera Pharma UK Limited
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2013-11-01
- Primary completion
- 2014-07-01
- Enrollment
- 108
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.